199 Randomised Phase II BGOG/ENGOT-cx1 Study of Paclitaxel-Carboplatin with or Without Nintedanib in First-Line Recurrent or Advanced Cervical CancerIB Vergote,E Van Nieuwenhuysen,A Casado,A Laenen,D Lorusso,I Braicu, E Guerra-Alia,P Zola,P Wimberger,P Debruyne,E Falcó,A Ferrero,MZ Muallem,J Kerger, E Garcia Martinez,S Pignata,J Sehouli,T Van Gorp,C Gennigens,MJ Rubio PérezCervical cancer(2021)引用 2|浏览7AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要